Three numbers in the abstract
Where each one falls
Where it lands on the map
the abstract, start to end
… glucose-lowering regimens (HR 2.17, 95% CI [1.73, 2.74]; p < 0.001), regimens excluding other GLP-1 receptor agonists (HR 2.13, 95% CI [1.60, 2.83]; p < 0.001), and sodium-glucose co-transporter 2 inhibitor (SGLT2i) users (HR 1.96, 95% CI [1.28, 2.99]; …
← favours treatmentfavours comparator →
could be chanceGlycemic control
HR 2.171.73–2.74
Glycemic control
HR 2.131.60–2.83
Glycemic control
HR 1.961.28–2.99
GLP-1 receptor agonistsOther glucose-loweringGlycemic control
1 / 3